Numinus Wellness received final approval from the Toronto Stock Exchange to graduate its listing to the TSX from the TSX-Venture Exchange.
One company is providing investors with the opportunity to contribute to novel mental health care solutions by participating in the growth of companies in the psychedelics...
The acquisition includes all future worldwide rights relating to the use of psychedelics to treat Alzheimer’s disease and other dementias.
UK-based psychedelics company Albert Labs has received conditional approval for the listing of its common shares on the Canadian Securities Exchange (CSE).
As regulation surrounding psychedelics develops across the globe, Numinus Wellness has created a toxicity and potency screening test that will facilitate safety and efficacy testing of...
The non-profit Mind Medicine Australia will be hosting the summit that will bring together leaders in the field of psychedelics to discuss the benefits of the...
Biotechnology company Beckley Psytech has welcomed neuroscience expert Dr Frank Wiegand to its team as Chief Medical Officer.
Levitee Labs has announced it has listed on the Frankfurt Stock Exchange (FSE).
Origin Therapeutics is poising for public listing on the Canadian Securities Exchange (CSE).
The End in Mind conference will bring together celebrities, healthcare and psychedelics experts and policy makers to explore the role that psychedelics can play in the...
